Hall Laurie J Trustee Prothena Corp Public LTD CO Transaction History

Hall Laurie J Trustee

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 11, 2023	SELL	$52.05 - $65.0 $1,561 - $1,950	-30 Reduced 37.5%	50 $3,000
Q3 2022 Oct 11, 2022	SELL	$25.16 - $60.63 $754 - $1,818	-30 Reduced 27.27%	80 $5,000
Q3 2021 Oct 04, 2021	SELL	$48.2 - $78.89 $10,604 - $17,355	-220 Reduced 66.67%	110 $8,000
Q3 2020 Oct 09, 2020	BUY	$9.93 - $13.47 $993 - $1,347	100 Added 43.48%	330 $3,000
Q4 2019 Feb 12, 2020	BUY	$7.48 - $17.01 $1,047 - $2,381	140 Added 155.56%	230 $4,000
Q4 2017 Jan 30, 2018	SELL	$35.44 - $63.76 $1,772 - $3,188	-50 Reduced 35.71%	90 $3,000
Q2 2017 Aug 22, 2017	BUY	N/A	140	140 $0

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $641M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Hall Laurie J Trustee, based on Form 13F filings with the SEC.

Stay updated on Hall Laurie J Trustee with notifications on news.